Dongwha Pharm.Co.,Ltd
KRX:000020.KS
7640 (KRW) • At close September 6, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) KRW.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 361,108.562 | 340,426.327 | 293,018.112 | 272,075.384 | 307,150.026 | 306,602.589 | 258,881.617 | 237,470.835 | 223,201.285 | 213,472.145 | 220,240.575 | 223,371.997 | 234,561.984 | 215,279.424 | 145,115.173 | 188,607.515 | 175,119.773 | 148,738.623 |
| Cost of Revenue
| 176,983.836 | 159,436.067 | 143,671.124 | 133,409.429 | 185,418.315 | 190,699.352 | 150,798.015 | 134,293.445 | 126,621.906 | 118,268.235 | 124,566.869 | 124,599.323 | 126,631.732 | 121,482.731 | 79,597.739 | 83,425.853 | 77,654.149 | 76,044.842 |
| Gross Profit
| 184,124.726 | 180,990.26 | 149,346.988 | 138,665.954 | 121,731.711 | 115,903.237 | 108,083.601 | 103,177.389 | 96,579.379 | 95,203.91 | 95,673.706 | 98,772.674 | 107,930.253 | 93,796.693 | 65,517.434 | 105,181.662 | 97,465.624 | 72,693.781 |
| Gross Profit Ratio
| 0.51 | 0.532 | 0.51 | 0.51 | 0.396 | 0.378 | 0.418 | 0.434 | 0.433 | 0.446 | 0.434 | 0.442 | 0.46 | 0.436 | 0.451 | 0.558 | 0.557 | 0.489 |
| Reseach & Development Expenses
| 20,370.756 | 19,284.569 | 17,338.114 | 16,912.071 | 16,261.864 | 15,604.538 | 14,078.034 | 13,717.406 | 13,329.278 | 11,770.852 | 1,363.463 | 851.304 | 1,078.47 | 66.24 | 248.412 | 311.188 | 1,402.527 | 440.704 |
| General & Administrative Expenses
| 12,697.111 | 10,882.732 | 8,997.109 | 8,388.132 | 8,592.388 | 8,405.339 | 8,158.168 | 7,171.015 | 7,950.525 | 7,729.064 | 7,456.88 | 6,517.657 | 6,292.475 | 6,428.453 | 4,821.803 | 5,699.196 | 4,319.952 | 4,169.291 |
| Selling & Marketing Expenses
| 77,547.158 | 65,741.462 | 47,417.364 | 42,436.921 | 40,862.478 | 39,873.192 | 37,418.813 | 35,008.539 | 35,156.768 | 32,991.941 | 43,453.091 | 37,986.01 | 34,044.714 | 34,234.661 | 19,835.249 | 24,942.796 | 28,564.698 | 22,419.735 |
| SG&A
| 143,565.381 | 76,624.194 | 56,414.473 | 50,825.053 | 49,454.866 | 48,278.531 | 45,576.981 | 42,179.554 | 43,107.293 | 40,721.005 | 50,909.971 | 44,503.667 | 40,337.189 | 40,663.114 | 24,657.052 | 30,641.992 | 32,884.65 | 26,589.026 |
| Other Expenses
| -342,332.682 | 55,166.419 | 53,095.899 | 47,771.592 | 46,097.235 | 400.753 | -1,669.547 | 21,730.549 | 133.782 | -2,801.13 | -2,303.22 | -2,310.159 | -5,680.131 | -4,513.788 | -2,105.381 | -3,049.174 | -4,623.194 | -3,074.269 |
| Operating Expenses
| 342,332.682 | 151,075.182 | 126,848.486 | 115,508.716 | 111,813.965 | 104,674.059 | 97,096.293 | 91,918.056 | 91,766.406 | 87,409.648 | 93,611.486 | 88,769.77 | 82,308.587 | 83,479.454 | 53,129.18 | 65,217.694 | 63,920.786 | 58,522.517 |
| Operating Income
| 18,775.88 | 29,915.078 | 22,496.351 | 23,153.371 | 17,094.968 | 11,225.78 | 10,987.308 | 11,259.334 | 4,812.974 | 7,794.263 | 2,062.22 | 10,002.904 | 25,621.666 | 10,317.239 | 12,388.252 | 39,963.969 | 33,544.838 | 14,171.262 |
| Operating Income Ratio
| 0.052 | 0.088 | 0.077 | 0.085 | 0.056 | 0.037 | 0.042 | 0.047 | 0.022 | 0.037 | 0.009 | 0.045 | 0.109 | 0.048 | 0.085 | 0.212 | 0.192 | 0.095 |
| Total Other Income Expenses Net
| 18,179.7 | -6,829.53 | 4,030.938 | 10,484.909 | -487.1 | 3,313.282 | 54,231.434 | 1,234.609 | 1,187.649 | -507.008 | -354.929 | -1,573.266 | -6,588.571 | -1,658.824 | -412.613 | 1,497.447 | -673.688 | -651.459 |
| Income Before Tax
| 36,955.58 | 23,085.548 | 26,527.289 | 33,638.28 | 16,607.868 | 14,539.062 | 65,218.743 | 35,655.076 | 6,000.623 | 5,401.942 | 889.905 | 8,429.638 | 19,033.095 | 5,430.195 | 11,975.639 | 41,461.416 | 32,871.15 | 13,519.803 |
| Income Before Tax Ratio
| 0.102 | 0.068 | 0.091 | 0.124 | 0.054 | 0.047 | 0.252 | 0.15 | 0.027 | 0.025 | 0.004 | 0.038 | 0.081 | 0.025 | 0.083 | 0.22 | 0.188 | 0.091 |
| Income Tax Expense
| 8,718.534 | 1,494.337 | 6,944.487 | 4,923.178 | 7,214.013 | 4,470.95 | 18,209.729 | 9,400.758 | 391.971 | 464.737 | -121.955 | 7,118.397 | 1,353.872 | 2.988 | 5,258.238 | 12,942.886 | 11,375.768 | 5,454.608 |
| Net Income
| 27,438.29 | 20,383.459 | 17,870.405 | 28,507.687 | 9,402.231 | 10,068.506 | 47,009.013 | 26,254.318 | 5,608.652 | 4,937.205 | 1,011.86 | 1,311.241 | 17,679.223 | 5,427.207 | 6,717.401 | 28,518.53 | 21,495.381 | 8,065.194 |
| Net Income Ratio
| 0.076 | 0.06 | 0.061 | 0.105 | 0.031 | 0.033 | 0.182 | 0.111 | 0.025 | 0.023 | 0.005 | 0.006 | 0.075 | 0.025 | 0.046 | 0.151 | 0.123 | 0.054 |
| EPS
| 991.07 | 736.42 | 646.68 | 1,032.6 | 330.2 | 365 | 1,700 | 949 | 202 | 177 | 36 | 47 | 633 | 194 | 240 | 1,021 | 769.6 | 288.8 |
| EPS Diluted
| 991.07 | 736.42 | 646.68 | 1,032.51 | 330.2 | 365 | 1,700 | 949 | 202 | 177 | 36 | 47 | 633 | 194 | 240 | 1,021 | 769.6 | 288.8 |
| EBITDA
| 18,775.88 | 43,896.031 | 37,437.196 | 35,233.998 | 28,579.647 | 22,211.116 | -32,035.864 | 46,164.183 | 18,001.074 | 18,545.673 | 13,777.069 | 21,770.508 | 33,435.592 | 25,821.59 | 26,787.06 | 44,455.866 | 36,420.748 | 17,417.165 |
| EBITDA Ratio
| 0.052 | 0.129 | 0.128 | 0.13 | 0.093 | 0.072 | -0.124 | 0.194 | 0.081 | 0.087 | 0.063 | 0.097 | 0.143 | 0.12 | 0.185 | 0.236 | 0.208 | 0.117 |